Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure

Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure

OBJECTIVES:. Studies of the use of IV N-acetylcysteine in the management of non-acetaminophen-induced acute liver failure have evaluated various dosing regimens. The only randomized trial studying this application described a 72-hour regimen. However, observational studies have reported extended dur...

Full description

Bibliographic Details
Main Authors: Stephanie N. Bass, PharmD, Mollie Lumpkin, PharmD, Eduardo Mireles-Cabodevila, MD, Christina C. Lindenmeyer, MD, Bridget Dolan, MPAS, Caleigh Pickett, MPAS, Aanchal Kapoor, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-05-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000411

Similar Items

Similar Items